Sort
48,018 grants matching “immunotherapy”
Binding and Presentation of Lipid Antigens by CD1
$410,850Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2010 · AI
Targeting Viral Envelope Glycoproteins with Synthetic Antibodies
$410,850Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2012 · AI
Targeting Viral Envelope Glycoproteins with Synthetic Antibodies
$410,850Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2011 · AI
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma
$410,835Hikmat Al-Ahmadie · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
$410,835Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma
$410,835Hikmat Al-Ahmadie · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma
$410,835Hikmat Al-Ahmadie · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
$410,835Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Developmental Funds
$410,800Leonidas C Platanias · Northwestern University At Chicago · P30 · FY2023 · CA
Developmental Funds
$410,800Leonidas C Platanias · Northwestern University At Chicago · P30 · FY2024 · CA
Microphysiological platform for analyzing multiple myeloma's tumor microenvironment, enabling immunotherapy assessment and drug screening.
$410,792Tania Tali Konry · Northeastern University · R33 · FY2025 · CA
The Role of HBeAg in HBV Persistence
$410,693Haitao Guo · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$410,675Robert M Prins · University Of California Los Angeles · R01 · FY2021 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$410,675Robert M Prins · University Of California Los Angeles · R01 · FY2019 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$410,675Robert M Prins · University Of California Los Angeles · R01 · FY2020 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$410,668Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer
$410,668Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Targeting exosomal PDL1 to improve immunotherapy
$410,622Wei Guo · Wistar Institute · P50 · FY2022 · CA
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
$410,606Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
$410,606Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Metabolic reprogramming of Tregs in tumor immunity
$410,606Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$410,606Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Metabolic reprogramming of Tregs in tumor immunity
$410,606Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$410,606Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Metabolic reprogramming of Tregs in tumor immunity
$410,606Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2019 · CA